In mice, the presence of CD8+ T-cells was monitored using 89Zr-labeled an anti-CD8 single domain antibody after treatment of B16 melanoma with an anti-CTLA-4, showing that response correlated with the homogeneity of the distribution of CD8+ T-cells through the tumors (58). The gene discussed is CD8A; the disease is melanoma.